BCHM 163 (BCHM163)
Hofstra University
All 5 results
Sort by
-
XL-765
- Package deal • 2 items • 2023
-
- $50.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
XL-765 cancer metabolism BCHM 163
- Summary • 3 pages • 2023
-
- $20.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
Presentation BCHM 163
- Presentation • 6 pages • 2023
- Available in package deal
-
- $20.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
Summary XL-765 BCHM 163
- Summary • 1 pages • 2023
- Available in package deal
-
- $20.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
Acriflavine Cancer Report
- Essay • 4 pages • 2020
-
- $8.49
- + learn more
This cancer report is on acriflavine. It includes detailed hand drawn figures with captions of the pathway being inhibited and a structure of the compound. In addition, there is a work cited page and information about the clinical phase, benefits and transcriptional activity of acriflavine.
Want to regain your expenses?
How much did you already spend on Stuvia? Imagine there are plenty more of you out there paying for study notes, but this time YOU are the seller. Ka-ching! Discover all about earning on Stuvia